Atypical presentation of Mycobacterium xenopi pulmonary infection in a kidney transplant recipient: A case report and literature review

被引:1
作者
Hamon, Antoine [1 ,4 ]
Liegeon, Geoffroy [1 ]
Louis, Kevin [2 ]
Cambau, Emmanuelle [3 ]
De Castro, Nathalie [1 ]
机构
[1] Paris C Univ, Hop St Louis, AP HP, Infect Dis Dept, 1 Ave Claude Vellefaux, F-75010 Paris, France
[2] Paris C Univ, Hop St Louis, AP HP, Nephrol & Renal Transplantat Dept, 1 Ave Claude Vellefaux, F-75010 Paris, France
[3] Paris C Univ, Hop Bichat, AP HP, Associate Lab,Natl Reference Ctr Mycobacteria & An, 46 Rue Henri Huchard, F-75018 Paris, France
[4] Paris C Univ, Hop St Louis, Infect Dis Dept, AP HP, Paris, France
关键词
Kidney transplantation; Mycobacterium xenopi; Non-tuberculous mycobacteria; TUBERCULOSIS; DISEASE;
D O I
10.1016/j.idcr.2022.e01675
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Mycobacterium xenopi is one of the most common pathogens responsible for non-tuberculosis mycobacteria (NTM) pulmonary diseases, which are associated with poor prognosis in immunocompromised patients.Case presentation: We report the unusual case of a 44-year-old kidney transplant recipient with multiple pul-monary nodules revealing M. xenopi pulmonary disease with atypical presentation. A three drug-regimen con-taining moxifloxacin, ethambutol and azithromycin was prescribed, with careful monitoring of the immunosuppressive therapy. The outcome was favorable. Discussion and conclusion: Although infrequent in kidney transplant recipients, NTM can cause pulmonary infection several years after transplantation. Treatment of M. xenopi infection relies on a multidrug regimen with at least 3 antimycobacterial drugs. Drug-drug interactions between immunosuppressive treatments and rifa-mycins require careful dose adjustment and monitoring to avoid graft rejection.
引用
收藏
页数:5
相关论文
共 20 条
[1]   Mycobacterium xenopi pulmonary infections: a multicentric retrospective study of 136 cases in north-east France [J].
Andrejak, C. ;
Lescure, F-X ;
Pukenyte, E. ;
Douadi, Y. ;
Yazdanpanah, Y. ;
Laurans, G. ;
Schmit, J-L ;
Jounieaux, V. .
THORAX, 2009, 64 (04) :291-296
[2]  
Andrejak C, 2016, AM THORAC SOC, DOI [10.1164/ajrccm-conference.2016.193.1_MeetingAbstracts.A3733, DOI 10.1164/AJRCCM-CONFERENCE.2016.193.1_MEETINGABSTRACTS.A3733]
[3]   Rifamycins - Obstacles and opportunities [J].
Aristoff, Paul A. ;
Garcia, George A. ;
Kirchhoff, Paul D. ;
Showalter, H. D. Hollis .
TUBERCULOSIS, 2010, 90 (02) :94-118
[4]   Clinical features and outcomes of tuberculosis in transplant recipients as compared with the general population: a retrospective matched cohort study [J].
Benito, N. ;
Garcia-Vazquez, E. ;
Horcajada, J. P. ;
Gonzalez, J. ;
Oppenheimer, F. ;
Cofan, F. ;
Ricart, M. J. ;
Rimola, A. ;
Navasa, M. ;
Rovira, M. ;
Roig, E. ;
Perez-Villa, F. ;
Cervera, C. ;
Moreno, A. .
CLINICAL MICROBIOLOGY AND INFECTION, 2015, 21 (07) :651-658
[5]  
Daley CL, 2020, CLIN INFECT DIS, V71, pE1, DOI 10.1093/cid/ciaa241
[6]  
GEISELER PJ, 1985, AM REV RESPIR DIS, V131, P944
[7]   The geographic diversity of nontuberculous mycobacteria isolated from pulmonary samples An NTM-NET collaborative study [J].
Hoefsloot, Wouter ;
Van Ingen, Jakko ;
Andrejak, Claire ;
Angeby, Kristian ;
Bauriaud, Rosine ;
Bemer, Pascale ;
Beylis, Natalie ;
Boeree, Martin J. ;
Cacho, Juana ;
Chihota, Violet ;
Chimara, Erica ;
Churchyard, Gavin ;
Cias, Raquel ;
Daza, Rosa ;
Daley, Charles L. ;
Dekhuijzen, P. N. Richard ;
Domingo, Diego ;
Drobniewski, Francis ;
Esteban, Jaime ;
Fauvilte-Dufaux, Maryse ;
Folkvardsen, Dorte Bek ;
Gibbons, Noel ;
Gomez-Mampaso, Enrique ;
Gonzalez, Rosa ;
Hoffmann, Harald ;
Hsueh, Po-Ren ;
Indra, Alexander ;
Jagielski, Tomasz ;
Jamieson, Frances ;
Jankovic, Mateja ;
Jong, Eefje ;
Keane, Joseph ;
Koh, Wo-Jung ;
Lange, Bent ;
Leao, Sylvia ;
Macedo, Rita ;
Mannsaker, Lurid ;
Marras, Theodore K. ;
Maugein, Jeannette ;
Milburn, Heather J. ;
Mlinko, Tannas ;
Morcillo, Nora ;
Morimoto, Kozo ;
Papaventsis, Dimitrios ;
Palenque, Elia ;
Paez-Peria, Mar ;
Piersimoni, Claudio ;
Polanova, Monika ;
Rastogi, Nalin ;
Richter, Elvira .
EUROPEAN RESPIRATORY JOURNAL, 2013, 42 (06) :1604-1613
[8]   Clarithromycin vs ciprofloxacin as adjuncts to rifampicin and ethambutol in treating opportunist mycobacterial lung diseases and an assessment of Mycobacterium vaccae immunotherapy [J].
Jenkins, P. A. ;
Campbell, I. A. ;
Banks, J. ;
Gelder, C. M. ;
Prescott, R. J. ;
Smith, A. P. .
THORAX, 2008, 63 (07) :627-634
[9]  
Jenkins PA, 2001, THORAX, V56, P167
[10]  
KOIZUMI JH, 1980, AM J CLIN PATHOL, V73, P826